Total Payments
$8,732
2024 Payments
$1,496
Companies
34
Transactions
463
Medicare Patients
6,576
Medicare Billing
$291,754
Payment Breakdown by Category
Food & Beverage$8,711 (99.8%)
Education$20.81 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,711 | 458 | 99.8% |
| Education | $20.81 | 5 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $1,738 | 55 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $789.82 | 57 | $0 (2024) |
| Amgen Inc. | $761.58 | 31 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $753.53 | 80 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $725.81 | 43 | $0 (2024) |
| PFIZER INC. | $679.14 | 39 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $589.46 | 27 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $550.92 | 31 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $368.64 | 16 | $0 (2023) |
| Merck Sharp & Dohme LLC | $354.97 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,496 | 84 | Abbott Laboratories ($255.93) |
| 2023 | $1,792 | 96 | Amgen Inc. ($205.01) |
| 2022 | $1,094 | 41 | Abbott Laboratories ($293.04) |
| 2021 | $629.21 | 22 | Abbott Laboratories ($375.55) |
| 2020 | $656.10 | 32 | Abbott Laboratories ($279.04) |
| 2019 | $904.23 | 58 | Janssen Pharmaceuticals, Inc ($141.66) |
| 2018 | $1,171 | 68 | Abbott Laboratories ($201.67) |
| 2017 | $989.17 | 62 | Novartis Pharmaceuticals Corporation ($187.14) |
All Payment Transactions
463 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: Heart Failure | ||||||
| 11/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $32.92 | General |
| Category: Cardio-renal | ||||||
| 11/19/2024 | Abbott Laboratories | JOT DX (Device) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: DIABETES | ||||||
| 11/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $30.29 | General |
| Category: Cardiology | ||||||
| 11/11/2024 | Abbott Laboratories | ASSURITY (Device) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/06/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $26.20 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $20.47 | General |
| 10/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/09/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $32.69 | General |
| Category: Cardiology | ||||||
| 09/25/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $29.26 | General |
| Category: Cardiovascular | ||||||
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/10/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $28.55 | General |
| Category: Diabetes | ||||||
| 09/02/2024 | Abbott Laboratories | MERLIN@HOME (Device) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Cardiac Rhythm Management | ||||||
| 08/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/27/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.73 | General |
| 08/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: Obesity | ||||||
| 08/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $31.05 | General |
| Category: DIABETES | ||||||
| 08/01/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $32.69 | General |
| Category: Cardiology | ||||||
| 07/31/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $24.63 | General |
| Category: Cardiovascular | ||||||
| 07/30/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $25.83 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/16/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/03/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $2.38 | General |
| Category: Cardiovascular | ||||||
| 07/03/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $0.61 | General |
| Category: Cardiovascular | ||||||
| 06/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,839 | 2,503 | $265,106 | $76,364 |
| 2022 | 10 | 1,633 | 2,181 | $237,785 | $69,680 |
| 2021 | 12 | 1,557 | 2,168 | $240,386 | $74,176 |
| 2020 | 11 | 1,547 | 2,130 | $250,993 | $71,534 |
Total Patients
6,576
Total Services
8,982
Medicare Billing
$291,754
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 313 | 455 | $83,872 | $32,449 | 38.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 62 | 64 | $37,488 | $9,126 | 24.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 58 | 102 | $25,444 | $6,720 | 26.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 117 | 117 | $22,932 | $6,248 | 27.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 677 | 897 | $32,561 | $5,766 | 17.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 43 | 43 | $12,965 | $4,174 | 32.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 74 | 75 | $14,700 | $3,992 | 27.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 352 | 505 | $18,332 | $3,080 | 16.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 20 | 20 | $2,720 | $1,271 | 46.7% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 19 | 52 | $4,662 | $1,201 | 25.8% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 24 | 34 | $1,360 | $848.56 | 62.4% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 13 | 72 | $2,664 | $674.82 | 25.3% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 27 | 27 | $3,494 | $302.38 | 8.7% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 16 | 16 | $1,026 | $281.44 | 27.4% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 24 | 24 | $888.00 | $231.36 | 26.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 290 | 415 | $75,656 | $29,641 | 39.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 55 | 58 | $33,974 | $9,709 | 28.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 103 | 104 | $20,384 | $5,704 | 28.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 611 | 807 | $29,294 | $5,317 | 18.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 46 | 90 | $22,451 | $5,289 | 23.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 83 | 86 | $16,856 | $4,625 | 27.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 30 | 30 | $9,233 | $2,803 | 30.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 314 | 439 | $15,936 | $2,705 | 17.0% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2022 | 24 | 63 | $5,648 | $1,388 | 24.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 22 | 22 | $2,992 | $1,197 | 40.0% |
About Dr. Michael Fowler, MD
Dr. Michael Fowler, MD is a Cardiovascular Disease healthcare provider based in Torrington, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750461992.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Fowler, MD has received a total of $8,732 in payments from pharmaceutical and medical device companies, with $1,496 received in 2024. These payments were reported across 463 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($8,711).
As a Medicare-enrolled provider, Fowler has provided services to 6,576 Medicare beneficiaries, totaling 8,982 services with total Medicare billing of $291,754. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Torrington, CT
- Active Since 10/16/2006
- Last Updated 08/23/2007
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1750461992
Products in Payments
- ELIQUIS (Drug) $790.34
- XARELTO (Drug) $725.81
- Repatha (Biological) $637.58
- Confirm Rx (Device) $486.58
- ENTRESTO (Drug) $451.62
- JARDIANCE (Drug) $425.89
- VERQUVO (Drug) $354.97
- LEQVIO (Drug) $338.20
- CAMZYOS (Drug) $299.02
- FARXIGA (Drug) $261.37
- Assurity Pacemaker (Device) $257.53
- PRALUENT (Drug) $252.53
- LifeVest (Device) $246.77
- JOT DX (Device) $246.53
- VYNDAQEL (Drug) $192.61
- CARDIOMEMS (Device) $183.39
- BRILINTA (Drug) $168.03
- CONFIRM RX (Device) $164.68
- PRADAXA (Drug) $163.57
- Merlin Connectivity and Remote (Device) $148.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Torrington
Robert Kahan, Md, MD
Cardiovascular Disease — Payments: $9,003
Cardiovascular Disease $9,003
Carrie Wolfberg, Md, MD
Cardiovascular Disease — Payments: $4,499
Cardiovascular Disease $4,499
Karisa Tobon
Cardiovascular Disease — Payments: $3,641
Cardiovascular Disease $3,641
Joseph Abreu, Md, MD
Cardiovascular Disease — Payments: $2,650
Cardiovascular Disease $2,650
Dr. Liran Blum, Md, MD
Cardiovascular Disease — Payments: $2,146
Cardiovascular Disease $2,146